BRAVE Act of 2025

The Building Resources and Access for Veterans' Mental Health Engagement Act of 2025, or the BRAVE Act of 2025 (HR6024), was introduced in the House on November 12, 2025, and subsequently referred to the Committee on Veterans' Affairs and the Committee on Armed Services. On December 3, 2025, it was further referred to the Subcommittee on Health. This indicates the bill is in the early stages of the legislative process. A companion bill, S609, has been introduced in the Senate, suggesting bipartisan and bicameral interest in the policy area. The bill's text focuses on improving mental health services of the Department of Veterans Affairs (VA). It addresses workforce improvements, Vet Center infrastructure, services for women veterans, and extends the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program. While the bill authorizes the VA to take certain actions and extends existing programs, it does not specify new, explicit funding amounts or appropriations. Therefore, while it creates a framework for potential expansion of services, actual funding for these initiatives would depend on subsequent appropriations legislation. Structural winners, should this bill advance and receive funding, would be healthcare providers specializing in mental health and veteran services, particularly those with existing VA contracts or those positioned to secure them. Companies like HCA Healthcare ($HCA) and Universal Health Services ($UHS) operate hospital systems that include behavioral health facilities, and could potentially benefit from increased VA demand for services. Centene Corporation ($CNC), as a managed care organization, could see increased enrollment or service provision if VA services are expanded and integrated with external providers. Labcorp Holdings Inc. ($LH) and IQVIA Holdings Inc. ($IQV), while not direct mental health providers, offer diagnostic and clinical research services that could see increased demand if VA mental health programs expand and require more robust data collection or specialized testing. Looking at recent market data, HCA Healthcare ($HCA) is currently at $483.92, up 3.44% over the last 7 days but down 9.46% over the last 30 days. Universal Health Services ($UHS) is at $181.33, down 0.42% over 7 days and down 7.94% over 30 days. Centene Corporation ($CNC) is at $35.4, up 11.32% over 7 days but down 18.19% over 30 days. Labcorp Holdings Inc. ($LH) is at $274.46, up 4.12% over 7 days and down 0.53% over 30 days. IQVIA Holdings Inc. ($IQV) is at $170.72, up 2.74% over 7 days and down 4.36% over 30 days. These recent movements reflect broader market dynamics and do not show a direct correlation to the early-stage legislative activity of the BRAVE Act, which has not yet secured funding. The next legislative steps for HR6024 include further consideration by the House Committees on Veterans' Affairs and Armed Services, and specifically the Subcommittee on Health. Given its early stage and the need for subsequent appropriations, any direct market impact is not immediate.